Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0020440 (
hypercapnia
)
7,939
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
1. Cerebral blood flow (CBF) in the rat was monitored by a venous outflow technique with an extracorporeal circulation which allowed for continuous monitoring of flow over the several hours of the study. 2. Brief challenges with carbon dioxide (CO2) increased the CBF. 3.
Nifedipine
(1.00 mg/kg), a dihydropyridine calcium antagonist, attenuated the response of the animal to
hypercapnia
, while leaving the basal flow rate unchanged. 4. This study may have significant implications as to the effect of nifedipine on CBF. 5. Since similar results have been obtained with nifedipine in anoxia, this study suggests that the responses to anoxia and
hypercapnia
are interrelated and that the resulting hyperemia may be governed by the same mechanisms.
...
PMID:Nifedipine reduces the increases in cerebral blood flow during hypercapnic episodes. 190 50
Acute effects of calcium channel blocker nifedipine were investigated in patients with chronic obstructive pulmonary disease (COPD. In the present study 10 patients were included in the early phase of COPD and 20 patients in the late phase with chronic respiratory insufficiency characterized with resting hypoxemia,
hypercapnia
and respiratory acidosis. The patients were examined before and after sublingual application of nifedipine (10 mg) or placebo in single-blind study design.
Nifedipine
did not alter spirometric parameters (FVC, FEV1, FEV1/FVC), except in the late phase of COPD (FEV1). However, acute nifedipine treatment significantly improved resting arterial blood gases: PaO2 increased in both groups while PaCO2 decreased only in the patients in advanced phase of COPD. Additionally, nifedipine increased DLCOSB in the early phase of COPD. Acute nifedipine was found to have a beneficial effect in COPD patients.
...
PMID:[The acute effect of nifedipine in chronic obstructive lung disease]. 279 77